Methylphenidate manufacturers

Common Questions and Answers about Methylphenidate manufacturers


AddERall (mixed salts of a single entity amphetamine product) Tablets AddERall XR (mixed salts of a single entity amphetamine product) Extended-Release Capsules ConcERta (<span style = 'background-color: #dae8f4'>Methylphenidate</span> hydrochloride) Extended-Release Tablets Daytrana (<span style = 'background-color: #dae8f4'>Methylphenidate</span>) TransdERmal System Desoxyn (methamphetamine HCl) Tablets Dexedrine (dextroamphetamine sulfate) Spansule Capsules and Tablets Focalin (dexMethylphenidate hydrochloride) Tablets Focalin XR (dexMethylphenidate hydrochloride) Extended-Releas
In a news release, drug manufacturER NextWave Pharmaceuticals announced FDA approval of its drug Qullivant XR (<span style = 'background-color: #dae8f4'>Methylphenidate</span> hydrochloride), the first once-daily, oral-suspension medication for the treatment of ADHD. According to the company, the central nERvous system stimulant is the first extended-release, once-daily liquid ADHD medication on the market. It helps control ADHD symptoms within 45 minutes of administration and lasts for 12 hours.